Panacos Pharmaceuticals, Inc. (OTCPK: PANC)
Health Care · Biotechnology · US
$—
— today · — 1Y
Panacos Pharmaceuticals, Inc. (OTCPK: PANC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $54.00 and employs 41 people.
trading between 0.00 and 0.00.
Tweenvest scores Panacos Pharmaceuticals, Inc. across four factors: value 50/100. Its strongest factor is value.
PANC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $54.00
- Revenue (TTM)
- $99.00K
- P/E
- —
- EPS
- -0.67
- Dividend yield
- —
- Beta (5Y)
- -14.57
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 53.64M
- Employees
- 41
- Next earnings
- —
About Panacos Pharmaceuticals, Inc.
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
- ISIN
- US69811Q1067
- Founded
- 1999
- Listed since
- Mar 14, 2005
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.40 | +0.54% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.50 | +0.49% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.48 | +0.25% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.19 | +0.03% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $835.00 | +0.12% |
| argenx SEENXTBR: ARGX | $65.85B | €877.20 | -2.75% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.53 | -1.06% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.